Please login to the form below
Ipsen
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Ipsen's 2013 oncology sales performance.
Botox strength bolsters Allergan ahead of AbbVie takeover
Rival drugmaker Ipsen has market exclusivity for its rival botulinum toxin drug Dysport (abobotulinumtoxinA) in lower-limb spasticity caused by cerebral palsy following its 2016 FDA approval.
New hires at Bristol-Myers Squibb, Acceleron and FerGene
pharmacoepidemiology. FerGene. FerGene has appointed David Meek (pictured left) as its new chief executive officer, who moves to the company from Ipsen. ... Most recently, he served as CEO of Ipsen, and he brings 30 years of industry experience to FerGene
Merck bulks up in cancer with $2.2bn Peloton buy
with Exelixis/Ipsen’s multikinase inhibitor Cabometyx (cabozantinib).
Ipsen buys rare disease group Clementia in $1.3bn deal
Ipsen could enter a potentially lucrative market with palovarotene for both FOP and MO, for which there are no current treatments approved for these types of diseases. ... possible. “We anticipate a smooth transition of our operations into the Ipsen
Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership team
Asad Mohsin Ali has been appointed general manager of Ipsen UK and Ireland. ... Ali’s new role will see him lead Ipsen’s commercial presence in the UK and Ireland.
[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Senior Medical Writer, MRNA/ Covid 19, Medical Communications, U...
-
Highly competitive salary
- SAD/ Group Account Director, Medical Communications, Remote UK
-
Highly competitive salary
-
Consultant Dermatologist (Freelance)
-
£110-180ph
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Biogen and MedRhythms sign deal worth over $120m for digital therapeutics for MS patients
- UK trial of fourth vaccine dose shows increased protection against COVID-19
- EIT Health and Biogen announce winners of first ‘neurotechprize’
- Biogen and Eisai announce FDA submission for early Alzheimer’s treatment
- Roche reinforces commitment to the World Federation of Hemophilia Humanitarian Aid Program
- FDA limits use of Janssen’s COVID-19 vaccine
- Holistic Excellence
- Bristol Myers Squibb releases positive trial results for plaque psoriasis treatment
- Scientists discover new approach to treat brain tumours
- SOLVE FSHD announces the appointment of Dr Eva Chin as its executive director
- Top 10 Creative Ways to Engage Your Advisors
- AI in Healthcare: How to Accelerate Change
- Biogen retracts EMA application for Alzheimer's drug Aduhelm
- BioXcel Therapeutics begins phase 3 trial for acute agitation in Alzheimer’s patients
- Kite’s new CAR T-cell therapy manufacturing facility given the go-ahead by the FDA
- WHO releases estimates of 14.9 million excess deaths during COVID-19 pandemic
- Patient journey mapping: exploring the clinical and the emotional journey
- The great reset of frontline HCP relationships
PMHub
Origins Insights
Origins are part of the Resonant Group. Using novel research methodologies, we dig deeper to deliver authentic audience experiences that...
Latest intelligence
- Food Allergy – Is avoidance the only option?
- Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
- Serious about sustainability?
- Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...
- How scientific storytelling can help Pharma cut through the noise
- Rather than being afraid of storytelling, pharmaceutical firms should be embracing it. Because what scientific storytelling allows us to do is to communicate quickly and efficiently. It provides a shortcut...
